Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 14 | 2024 | 1808 | 3.680 |
Why?
|
| Postmenopause | 8 | 2023 | 2461 | 2.070 |
Why?
|
| Sleep | 19 | 2023 | 4604 | 2.000 |
Why?
|
| Ovarian Neoplasms | 10 | 2021 | 4823 | 1.440 |
Why?
|
| Ovulation | 2 | 2020 | 189 | 1.390 |
Why?
|
| Neoplasms, Glandular and Epithelial | 4 | 2016 | 484 | 1.270 |
Why?
|
| Circadian Rhythm | 6 | 2023 | 2623 | 1.250 |
Why?
|
| Adiposity | 5 | 2019 | 1806 | 1.170 |
Why?
|
| Hyperglycemia | 3 | 2022 | 1368 | 1.010 |
Why?
|
| Parity | 2 | 2019 | 929 | 1.010 |
Why?
|
| Atherosclerosis | 9 | 2023 | 3428 | 0.990 |
Why?
|
| Spinal Fractures | 2 | 2022 | 698 | 0.980 |
Why?
|
| Actigraphy | 6 | 2023 | 488 | 0.960 |
Why?
|
| Premenopause | 2 | 2020 | 1033 | 0.940 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 4 | 2021 | 997 | 0.930 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2023 | 11695 | 0.920 |
Why?
|
| C-Reactive Protein | 4 | 2024 | 3766 | 0.890 |
Why?
|
| Hip Fractures | 2 | 2022 | 954 | 0.880 |
Why?
|
| Receptors, Leptin | 4 | 2019 | 356 | 0.830 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2023 | 269 | 0.830 |
Why?
|
| Ovarian Function Tests | 1 | 2020 | 11 | 0.760 |
Why?
|
| Nurses | 5 | 2023 | 2459 | 0.750 |
Why?
|
| Dehydroepiandrosterone | 2 | 2019 | 252 | 0.720 |
Why?
|
| Phthalic Acids | 5 | 2016 | 436 | 0.720 |
Why?
|
| Prospective Studies | 31 | 2023 | 53187 | 0.690 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 2043 | 0.680 |
Why?
|
| Diet, Vegetarian | 1 | 2019 | 173 | 0.610 |
Why?
|
| Risk Factors | 35 | 2024 | 72145 | 0.600 |
Why?
|
| Menopause | 4 | 2023 | 1621 | 0.600 |
Why?
|
| Body Mass Index | 14 | 2022 | 12695 | 0.590 |
Why?
|
| Contraceptives, Oral | 1 | 2019 | 563 | 0.590 |
Why?
|
| Adipokines | 2 | 2016 | 318 | 0.580 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15108 | 0.540 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2016 | 202 | 0.530 |
Why?
|
| Cross-Sectional Studies | 19 | 2023 | 24913 | 0.520 |
Why?
|
| Amino Acids | 2 | 2022 | 1727 | 0.520 |
Why?
|
| Obesity | 8 | 2023 | 12705 | 0.510 |
Why?
|
| Ovary | 1 | 2019 | 981 | 0.510 |
Why?
|
| Diet | 5 | 2022 | 7923 | 0.500 |
Why?
|
| Self Report | 4 | 2023 | 3548 | 0.500 |
Why?
|
| Female | 63 | 2023 | 379592 | 0.490 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 39004 | 0.470 |
Why?
|
| Depression | 7 | 2022 | 7733 | 0.460 |
Why?
|
| Pregnancy in Diabetics | 1 | 2014 | 179 | 0.450 |
Why?
|
| Middle Aged | 43 | 2023 | 213127 | 0.450 |
Why?
|
| Child Abuse | 1 | 2022 | 1030 | 0.450 |
Why?
|
| Environmental Pollutants | 4 | 2016 | 1180 | 0.450 |
Why?
|
| Hydrocortisone | 2 | 2019 | 1825 | 0.440 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 2861 | 0.440 |
Why?
|
| Blood Glucose | 6 | 2022 | 6249 | 0.430 |
Why?
|
| Postpartum Period | 3 | 2017 | 1078 | 0.430 |
Why?
|
| Obesity, Abdominal | 1 | 2016 | 361 | 0.430 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 657 | 0.430 |
Why?
|
| Longevity | 1 | 2020 | 1069 | 0.420 |
Why?
|
| Leptin | 5 | 2023 | 1593 | 0.420 |
Why?
|
| Humans | 80 | 2024 | 742088 | 0.410 |
Why?
|
| Hypertension | 4 | 2021 | 8455 | 0.410 |
Why?
|
| Coronary Disease | 4 | 2022 | 6078 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1889 | 0.390 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 378 | 0.390 |
Why?
|
| Inflammation | 6 | 2023 | 10578 | 0.390 |
Why?
|
| Endocrine Disruptors | 1 | 2014 | 237 | 0.380 |
Why?
|
| Adiponectin | 5 | 2023 | 1099 | 0.370 |
Why?
|
| Adult | 36 | 2023 | 213712 | 0.370 |
Why?
|
| Insulin | 7 | 2022 | 6575 | 0.350 |
Why?
|
| Sex Factors | 3 | 2019 | 10392 | 0.350 |
Why?
|
| Incidence | 8 | 2022 | 20928 | 0.340 |
Why?
|
| Insulin Resistance | 1 | 2022 | 3861 | 0.330 |
Why?
|
| Sleep Deprivation | 4 | 2023 | 830 | 0.310 |
Why?
|
| Life Style | 5 | 2023 | 3824 | 0.300 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3278 | 0.290 |
Why?
|
| Age Factors | 3 | 2020 | 18355 | 0.290 |
Why?
|
| Time Factors | 8 | 2021 | 40054 | 0.290 |
Why?
|
| Aged | 25 | 2023 | 162944 | 0.280 |
Why?
|
| Saliva | 3 | 2019 | 805 | 0.270 |
Why?
|
| Motor Activity | 1 | 2015 | 2714 | 0.260 |
Why?
|
| Health Surveys | 4 | 2020 | 4030 | 0.250 |
Why?
|
| Stress, Psychological | 2 | 2022 | 4229 | 0.250 |
Why?
|
| Polysomnography | 5 | 2023 | 1772 | 0.250 |
Why?
|
| Overweight | 2 | 2017 | 2366 | 0.240 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2019 | 703 | 0.240 |
Why?
|
| United States | 15 | 2023 | 69693 | 0.230 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3187 | 0.230 |
Why?
|
| Noise, Transportation | 1 | 2023 | 50 | 0.220 |
Why?
|
| Longitudinal Studies | 6 | 2022 | 13921 | 0.210 |
Why?
|
| Metabolomics | 2 | 2021 | 1467 | 0.200 |
Why?
|
| Aging | 2 | 2021 | 8626 | 0.200 |
Why?
|
| Fasting | 2 | 2019 | 1589 | 0.190 |
Why?
|
| Lipids | 3 | 2022 | 3302 | 0.190 |
Why?
|
| Snoring | 1 | 2022 | 189 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8425 | 0.180 |
Why?
|
| Ownership | 1 | 2022 | 331 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.180 |
Why?
|
| C-Peptide | 2 | 2018 | 416 | 0.180 |
Why?
|
| Comorbidity | 3 | 2020 | 10372 | 0.170 |
Why?
|
| Basal Metabolism | 1 | 2020 | 168 | 0.170 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 12344 | 0.160 |
Why?
|
| Prevalence | 4 | 2019 | 15194 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 689 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2019 | 3199 | 0.160 |
Why?
|
| Nails | 1 | 2019 | 291 | 0.150 |
Why?
|
| Health Occupations | 1 | 2018 | 223 | 0.140 |
Why?
|
| Male | 21 | 2023 | 349538 | 0.140 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 707 | 0.140 |
Why?
|
| Maternal Age | 1 | 2019 | 802 | 0.140 |
Why?
|
| Prolactin | 1 | 2018 | 669 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2019 | 9846 | 0.140 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2019 | 260 | 0.140 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 782 | 0.140 |
Why?
|
| Hyperhomocysteinemia | 1 | 2016 | 124 | 0.140 |
Why?
|
| Hair | 1 | 2019 | 483 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2018 | 660 | 0.130 |
Why?
|
| Nutrition Surveys | 4 | 2017 | 1656 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 1239 | 0.130 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 977 | 0.130 |
Why?
|
| Sleep, REM | 1 | 2019 | 594 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 192 | 0.130 |
Why?
|
| Flavones | 1 | 2014 | 66 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1517 | 0.120 |
Why?
|
| Risk | 3 | 2017 | 9679 | 0.120 |
Why?
|
| Flavanones | 1 | 2014 | 72 | 0.120 |
Why?
|
| Anthocyanins | 1 | 2014 | 76 | 0.120 |
Why?
|
| Flavonols | 1 | 2014 | 83 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 1 | 2017 | 553 | 0.120 |
Why?
|
| Politics | 1 | 2020 | 790 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2022 | 4248 | 0.110 |
Why?
|
| Spine | 1 | 2020 | 1143 | 0.110 |
Why?
|
| Insulin Infusion Systems | 1 | 2014 | 212 | 0.110 |
Why?
|
| Anthropometry | 1 | 2018 | 1350 | 0.110 |
Why?
|
| Feces | 1 | 2019 | 1394 | 0.110 |
Why?
|
| Mexican Americans | 1 | 2014 | 166 | 0.110 |
Why?
|
| Folic Acid | 2 | 2016 | 1300 | 0.110 |
Why?
|
| Exercise | 2 | 2022 | 5611 | 0.110 |
Why?
|
| Adolescent | 6 | 2022 | 85649 | 0.110 |
Why?
|
| Environmental Exposure | 3 | 2023 | 4231 | 0.110 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 851 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2018 | 927 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 577 | 0.100 |
Why?
|
| Pregnancy | 5 | 2017 | 29087 | 0.100 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 1150 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2713 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 21596 | 0.100 |
Why?
|
| Linear Models | 2 | 2019 | 5948 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2018 | 1202 | 0.100 |
Why?
|
| Physical Fitness | 1 | 2016 | 732 | 0.100 |
Why?
|
| Flavonoids | 1 | 2014 | 443 | 0.100 |
Why?
|
| Stroke | 3 | 2023 | 9963 | 0.100 |
Why?
|
| Body Weight | 2 | 2019 | 4664 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 941 | 0.090 |
Why?
|
| Wakefulness | 1 | 2017 | 1243 | 0.090 |
Why?
|
| Environmental Monitoring | 2 | 2014 | 1413 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 1149 | 0.090 |
Why?
|
| Diet, Mediterranean | 1 | 2016 | 696 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5724 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77098 | 0.090 |
Why?
|
| Brain | 1 | 2016 | 26343 | 0.080 |
Why?
|
| Young Adult | 8 | 2022 | 56350 | 0.080 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.080 |
Why?
|
| Anxiety | 2 | 2022 | 4279 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2195 | 0.080 |
Why?
|
| Boston | 3 | 2016 | 9305 | 0.080 |
Why?
|
| Child | 4 | 2022 | 77478 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12242 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2023 | 548 | 0.080 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 2354 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 17400 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19862 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2016 | 1184 | 0.070 |
Why?
|
| Prognosis | 2 | 2019 | 29010 | 0.070 |
Why?
|
| Weight Gain | 1 | 2016 | 2282 | 0.070 |
Why?
|
| Logistic Models | 3 | 2016 | 13403 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2940 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2016 | 2616 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4440 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8077 | 0.060 |
Why?
|
| Cholesterol, HDL | 2 | 2023 | 1813 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 57683 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 2838 | 0.060 |
Why?
|
| Weight Loss | 1 | 2014 | 2604 | 0.060 |
Why?
|
| Research Design | 1 | 2019 | 5979 | 0.060 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 109 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6454 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11690 | 0.050 |
Why?
|
| Aircraft | 1 | 2023 | 123 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 2866 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2022 | 198 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21719 | 0.050 |
Why?
|
| Psychomotor Agitation | 1 | 2023 | 288 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2016 | 8541 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 568 | 0.040 |
Why?
|
| Tomography | 1 | 2021 | 388 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 40955 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 711 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13256 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 884 | 0.040 |
Why?
|
| Horses | 1 | 2019 | 304 | 0.040 |
Why?
|
| Work Schedule Tolerance | 1 | 2022 | 565 | 0.040 |
Why?
|
| Health Status | 2 | 2023 | 4030 | 0.040 |
Why?
|
| Beverages | 1 | 2023 | 820 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2022 | 1532 | 0.040 |
Why?
|
| Metabolome | 1 | 2023 | 881 | 0.030 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2016 | 81 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 723 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15244 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 2021 | 0.030 |
Why?
|
| Meat | 1 | 2019 | 595 | 0.030 |
Why?
|
| Immunoassay | 1 | 2018 | 752 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 423 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2016 | 311 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 168561 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23320 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 732 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 438 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23387 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12220 | 0.030 |
Why?
|
| Tea | 1 | 2014 | 275 | 0.030 |
Why?
|
| Testosterone | 1 | 2023 | 2401 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 1574 | 0.030 |
Why?
|
| Mothers | 1 | 2022 | 2163 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3502 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 2684 | 0.020 |
Why?
|
| Emotions | 1 | 2023 | 2657 | 0.020 |
Why?
|
| Pregnant Women | 1 | 2016 | 566 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2017 | 1088 | 0.020 |
Why?
|
| China | 1 | 2016 | 2246 | 0.020 |
Why?
|
| Calcium | 1 | 2023 | 5753 | 0.020 |
Why?
|
| Educational Status | 1 | 2017 | 2533 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2016 | 961 | 0.020 |
Why?
|
| Triglycerides | 1 | 2016 | 2450 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 2014 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6452 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6365 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7167 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2022 | 40450 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2016 | 3294 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8328 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9826 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9941 | 0.010 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(99)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_